GEN-MKT-18-7897-A
Feb 15, 2017 | Biopharma, Blogs | 0 comments
Did you know the X500B QTOF system makes point and click workflows for Biologics Characterization possible on your mass spectrometer? The newly-designed SCIEX OS software interface brings to life fluid navigation and ease of use so you can keep moving forward on your scientific discoveries. In fact, it’s so simple to learn and operate that you and your team can be up and running faster than you might expect.
Hard to believe? Check out our new video series and see how easy it can be to get started with SCIEX OS on the X500B QTOF system.
Move Your Biotherapeutic Along FasterWhat’s different with the X500B? The new SCIEX OS software was built from the ground up to facilitate the X500B’s usability for every scientist, not just mass spec experts. The software uses an intuitive, icon-oriented interface so you can logically set up and optimize new methods. Instead of spending time and money on advanced training, you simply get to work. What’s more, SCIEX OS software features simple point and click method-building tools to create and optimize high-performance methods.
Let Your Productivity Soar the X500B QTOF and SCIEX OS Software:
You’ll be surprised how simple it is to increase your productivity.
Watch the short SCIEX OS introduction video series to see how easy it is for you to get fast, high-quality results in the point and click world.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network